Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 834.74% | -20.40% | -14.90% | -14.90% | 23.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44,588.50% | -8.41% | 0.75% | 0.75% | -98.40% |
| Operating Income | -43,459.29% | 8.41% | -0.75% | -0.75% | 98.40% |
| Income Before Tax | -1,952.72% | 59.17% | -45.67% | -45.67% | 183.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,952.55% | 59.17% | -45.67% | -45.67% | 183.47% |
| Earnings from Discontinued Operations | 1,059.25% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 199.06% | 64.67% | -45.67% | -45.67% | 13.32% |
| EBIT | -43,459.29% | 8.41% | -0.75% | -0.75% | 98.40% |
| EBITDA | -9,352.17% | 6.33% | -13.91% | -13.91% | 109.64% |
| EPS Basic | 168.47% | 71.85% | -34.64% | -34.64% | 19.87% |
| Normalized Basic EPS | -628.92% | 67.46% | -34.64% | -34.64% | 177.17% |
| EPS Diluted | 168.47% | 71.85% | -34.64% | -34.64% | 19.87% |
| Normalized Diluted EPS | -628.92% | 67.46% | -34.64% | -34.64% | 177.17% |
| Average Basic Shares Outstanding | 44.67% | 25.48% | 8.20% | 8.20% | 8.17% |
| Average Diluted Shares Outstanding | 44.67% | 25.48% | 8.20% | 8.20% | 8.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |